Real World Treatment Patterns and Outcomes among Unresectable Stage III Non-Small Cell Lung Cancer Patients Initiating Chemoradiotherapy

被引：0
|
作者：
Arunachalam, A. [1 ]
Vasudevan, A. [2 ]
Sura, S. [2 ]
Murphy, J. [2 ]
Goldschmidt, J. [3 ]
机构：
[1] Merck & Co Inc, Rahway, NJ USA
[2] Ontada, Irving, TX USA
[3] Blue Ridge Canc Care, Blacksburg, VA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
unresectable Stage III NSCLC; chemoradiation therapy; durvalumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP05.01-00
引用
收藏
页码：S264 / S265
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
    Arunachalam, Ashwini
    Sura, Sneha
    Murphy, John
    Conkling, Paul
    Goldschmidt, Jerome
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E13 - E13
  • [2] Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study
    Horinouchi, Hidehito
    Atagi, Shinji
    Oizumi, Satoshi
    Ohashi, Kadoaki
    Kato, Tomohiro
    Kozuki, Toshiyuki
    Seike, Masahiro
    Sone, Takashi
    Sobue, Tomotaka
    Tokito, Takaaki
    Harada, Hideyuki
    Maeda, Tadashi
    Mio, Tadashi
    Shirosaka, Ikue
    Hattori, Kana
    Shin, Eisei
    Murakami, Haruyasu
    [J]. CANCER MEDICINE, 2020, 9 (18): : 6597 - 6608
  • [3] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [4] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    [J]. JAMA NETWORK OPEN, 2024, 7 (04)
  • [5] Real World Chemoradiotherapy Outcomes for Frail Older Adults with Unresectable Stage III Non Small Cell Lung Cancer (NSCLC)
    Fletcher, J.
    Pringle, N.
    Mullally, W.
    O'Byrne, K.
    Xu, W.
    Ladwa, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S568 - S568
  • [6] Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy
    Oh, H. -J.
    Park, C. -K.
    Kim, Y. -C.
    Kim, Y. -H.
    Ahn, S. -J.
    Jeong, W. G.
    Lee, J. Y.
    Lee, J. C.
    Choi, C. M.
    Ji, W.
    Song, S. Y.
    Choi, J.
    Lee, S. Y.
    Kim, H.
    Lee, S. Y.
    Park, J.
    Yoon, S. H.
    Joo, J. H.
    Oh, I. -J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S294 - S295
  • [7] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Kellie J. Ryan
    Karen E. Skinner
    Ancilla W. Fernandes
    Rajeshwari S. Punekar
    Melissa Pavilack
    Mark S. Walker
    Noam A. VanderWalde
    [J]. Medical Oncology, 2019, 36
  • [8] Real-world outcomes in patients with unresected stage III non-small cell lung cancer
    Ryan, Kellie J.
    Skinner, Karen E.
    Fernandes, Ancilla W.
    Punekar, Rajeshwari S.
    Pavilack, Melissa
    Walker, Mark S.
    VanderWalde, Noam A.
    [J]. MEDICAL ONCOLOGY, 2019, 36 (03)
  • [9] Real world assessment of clinical benefit with consolidation durvalumab following chemoradiotherapy in stage III unresectable non-small cell lung cancer
    Marur, Shanthi
    Mangurian, Mark
    Wise, Corey
    Pozotrigo, Melissa
    Marur, Shika
    Norden, Andrew D.
    Toler, Andrew
    Bobolts, Laura Rose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Treatment Patterns and Outcomes of Stage III Non-Small Cell Lung Cancer (NSCLC): Real World Evidence of How our Patients Fare
    Yusuf, D.
    Walton, R.
    Hurry, M.
    Cheung, W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S626 - S626
12345